NYSE:CXE

MFS High Income Municipal Trust (CXE) Stock Forecast, Price & News

$3.48

+0.04 (+1.16%)

(As of 05/31/2023 ET)

Compare

Today's Range: $3.45
▼
$3.48
50-Day Range: $3.36
▼
$3.65
52-Week Range: $3.14
▼
$4.41

Volume: 27,010 shs
Average Volume: 77,840 shs
Market Capitalization: $109.72 million

P/E Ratio: N/A
Dividend Yield: 5.17%
Price Target: N/A

About MFS High Income Municipal Trust (NYSE:CXE) Stock

MFS High Income Municipal Trust is a closed-end management investment company. Its objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The company was founded on January 9, 1989 and is headquartered in Boston, MA.

Receive CXE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MFS High Income Municipal Trust and its competitors with MarketBeat's FREE daily newsletter.

CXE Stock News Headlines

May 27, 2023 | ca.finance.yahoo.com

CXE - MFS High Income Municipal Trust

May 15, 2023 | americanbankingnews.com

MFS High Income Municipal Trust (NYSE:CXE) to Issue Monthly Dividend of $0.01

May 31, 2023 | Behind the Markets (Ad)

[BREAKING] New "Living Missile" to Replace Nuclear Missiles

CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!

May 4, 2023 | americanbankingnews.com

Short Interest in MFS High Income Municipal Trust (NYSE:CXE) Drops By 6.5%

April 16, 2023 | americanbankingnews.com

MFS High Income Municipal Trust (CXE) to Issue Monthly Dividend of $0.01 on April 28th

December 2, 2022 | seekingalpha.com

MFS High Income Municipal Trust declares $0.015 dividend

April 14, 2022 | benzinga.com

Monday Is Your Last Chance To Buy Mfs High Inc Municipal Before The Dividend Payout

April 5, 2022 | seekingalpha.com

MFS High Income Municipal Trust declares $0.0175 dividend

May 31, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

March 4, 2022 | seekingalpha.com

MFS High Income Municipal Trust raises dividend by 3%

July 23, 2021 | barrons.com

MFS High Income Municipal Trust

March 3, 2021 | seekingalpha.com

MFS High Income Municipal Trust declares $0.021 dividend

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive CXE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MFS High Income Municipal Trust and its competitors with MarketBeat's FREE daily newsletter.

CXE Company Calendar

Ex-Dividend for 4/28 Dividend: 4/18/2023
Dividend Payable: 4/28/2023
Ex-Dividend for 5/31 Dividend: 5/16/2023
Today: 5/31/2023
Dividend Payable: 5/31/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Investment offices, not elsewhere classified
Sub-Industry: N/A
Sector: Finance
Current Symbol: NYSE:CXE
CUSIP: N/A
CIK: 845606
Web: www.mfs.com
Phone: (617) 954-5000
Fax: N/A
Employees: 147,000
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 31,530,000
Free Float: N/A
Market Cap: $109.72 million
Optionable: Not Optionable
Beta: 0.56

Key Executives

David L. DiLorenzo
President

Rosa E. Licea-Mailloux
Chief Compliance Officer

Christopher R. Bohane
Assistant Secretary

Susan A. Pereira
Assistant Secretary

Brian E. Langenfeld
Assistant Secretary

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

CXE Stock - Frequently Asked Questions

How have CXE shares performed in 2023?: MFS High Income Municipal Trust's stock was trading at $3.49 on January 1st, 2023. Since then, CXE shares have decreased by 0.3% and is now trading at $3.48.
View the best growth stocks for 2023 here.
Are investors shorting MFS High Income Municipal Trust?: MFS High Income Municipal Trust saw a drop in short interest in May. As of May 15th, there was short interest totaling 9,900 shares, a drop of 28.3% from the April 30th total of 13,800 shares. Based on an average trading volume of 66,900 shares, the days-to-cover ratio is presently 0.1 days.
View MFS High Income Municipal Trust's Short Interest.
How often does MFS High Income Municipal Trust pay dividends? What is the dividend yield for MFS High Income Municipal Trust?: MFS High Income Municipal Trust announced a monthly dividend on Monday, May 1st. Investors of record on Wednesday, May 17th will be given a dividend of $0.013 per share on Wednesday, May 31st. This represents a $0.16 dividend on an annualized basis and a yield of 4.48%. The ex-dividend date of this dividend is Tuesday, May 16th.
Read our dividend analysis for CXE.
What ETF holds MFS High Income Municipal Trust's stock ?: VanEck CEF Municipal Income ETF holds 243,261 shares of CXE stock, representing 0.42% of its portfolio.
Is MFS High Income Municipal Trust a good dividend stock?: MFS High Income Municipal Trust (NYSE:CXE) pays an annual dividend of $0.18 per share and currently has a dividend yield of 5.24%. CXE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for CXE.
What is MFS High Income Municipal Trust's stock symbol?: MFS High Income Municipal Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "CXE."

Who are MFS High Income Municipal Trust's major shareholders?: MFS High Income Municipal Trust's stock is owned by many different retail and institutional investors. Top institutional shareholders include Bank of America Corp DE (2.95%), Commonwealth Equity Services LLC (2.31%), UBS Group AG (2.06%), Van ECK Associates Corp (0.74%), Truist Financial Corp (0.33%) and Drive Wealth Management LLC (0.12%).
How do I buy shares of MFS High Income Municipal Trust?: Shares of CXE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is MFS High Income Municipal Trust's stock price today?: One share of CXE stock can currently be purchased for approximately $3.48.
How much money does MFS High Income Municipal Trust make?: MFS High Income Municipal Trust (NYSE:CXE) has a market capitalization of $109.72 million.
How many employees does MFS High Income Municipal Trust have?: The company employs 147,000 workers across the globe.
How can I contact MFS High Income Municipal Trust?: The official website for the company is www.mfs.com. The company can be reached via phone at (617) 954-5000.

This page (NYSE:CXE) was last updated on 5/31/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial